Skip to main content

Table 2 Concomitant medications by group of treatment

From: Clinical outcomes of paliperidone long-acting injection in patients with schizophrenia: a 1-year retrospective cohort study

 

NLAI (N = 289)

LAI (N = 178)

p

Oral antipsychotics (%)

269 (93.1)

28 (15.9)

< 0.0001

 Risperidone

77 (28.6)

1 (3.6)

 

 Paliperidone

69 (25.6)

13 (46.4)

 

 Quetiapine

40 (14.9)

11 (39.3)

 

 Olanzapine

38 (14.1)

3 (10.7)

 

 Aripiprazole

15 (5.6)

  

 Amisulpride

12 (4.5)

  

 Ziprasidone

8 (3.0)

  

 Clozapine

5 (1.9)

  

 Zotepine

3 (1.1)

  

 Lurasidone

2 (0.7)

  

Sedatives/hypnotics (%)

156 (54.0)

39 (22.2)

< 0.0001

Anticonvulsant (%)

93 (32.2)

60 (34.1)

0.761

Antidepressant (%)

98 (33.9)

32 (18.2)

0.0002

Anxiolytics (%)

23 (8.0)

67 (38.1)

< 0.0001

Anticholinergics (%)

56 (19.4)

21 (11.9)

0.00395

β-blocker (%)

26 (9.0)

20 (11.2)

0.429

  1. Fisher exact test was used to compare differences between groups